Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Zapping a deep belly muscle may give CrossFitters a squat edge

NCT ID NCT07684534

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests whether a minimally invasive technique called ultrasound-guided percutaneous neuromodulation can improve squat performance in healthy CrossFit practitioners. The procedure uses a thin needle to deliver mild electrical pulses to nerves that control a deep trunk muscle involved in stability and force transfer. Researchers will measure squat speed and power before and after the treatment, comparing it to a sham (fake) procedure to see if there is a real benefit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ultrasound-guided percutaneous neuromodulation
What this could lead to
If effective, this technique could offer a non-drug way to temporarily boost athletic performance in squat exercises.
What could go wrong
This is a small, early-stage trial with only 42 participants, and the effect may be minimal or no better than a sham procedure. Results may not apply to other exercises or sports.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 42 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 60 years * At least 1 year of CrossFit training experience * Training frequency between 2 and 6 sessions per week Exclusion Criteria: * Belonephobia (fear of needles) * Presence of cardiac conditions or implanted cardiac devices (e.g., pacemaker) * Pregnancy * Active oncological process * Skin conditions or lesions in the intervention area * Neurological or neurosensory disorders * Epilepsy * Current febrile condition * Recent use of antibiotics * Treatment with anticoagulant medication * Use of medications that may affect physical performance * Autoimmune diseases or use of immunosuppressive therapy * Active lumbar or abdominal pathology * Recent lumbar surgery or operations related to the intervention area * Active musculoskeletal injury or pain affecting squat technique or -performance * Undiagnosed pain affecting execution of the sporting movement.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Crossfit are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fisiosport premium SL

    RECRUITING

    Murcia, Murcia, 30007, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.